September 2024

– Approval based on the EV-302 trial where the treatment combination nearly doubled median overall survival and significantly extended progression free survival compared to platinum-containing chemotherapy, the current standard of care for first-line treatment of radically unresectable urothel

HONG KONG, Sept. 24, 2024 /PRNewswire/ — The Microfilm Production Support Scheme (Music) (“Support Scheme”), organized by the Hong Kong Interactive Marketing Association (“AIM”) and sponsored by the Cultural and Creative Industries Development Agency (“CCIDA&#822

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: